Revance Therapeutics

Ebit 변화 날짜
AbbVie USD 4.52B 378M 2023-09
ALKERMES USD 49.85M 189.34M 2023-09
Bristol-Myers Squibb USD 2.61B 104M 2023-12
Eli Lilly USD 3.08B 347.4M 2023-12
Merck USD -299000000 6.8B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pacira USD 33.97M 12.89M 2023-12
Supernus Pharmaceuticals USD 19.19M 11.06M 2023-12



Revance Therapeutics - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Apr 2024.